SCHEMBL7042573

SCHEMBL7042573

CC(C)c1cc(-c2cccc(C(=O)CC(=O)NN(C(=O)OC(C)(C)C)c3ccc(C(F)(F)F)cc3)c2)ccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
MDM2 Q00987 1/20 0.34
AAK1 Q2M2I8 5/20 0.33
MAP2K4 P45985 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
BRAF P15056 1/20 0.32
DGAT2 Q96PD7 1/20 0.32
FFAR1 O14842 1/20 0.32
SYK P43405 1/20 0.32
RORA P35398 1/20 0.32
NR2E1 Q9Y466 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7113350 0.89 RXRA (0.40) RXRANR1H2NR1H3MAP2K4DGAT2
SCHEMBL5558688 0.79 MEN1 (0.41) RXRANR1H2NR1H3AAK1MAP2K4
SCHEMBL6477551 0.79 MEN1 (0.37) RXRANR1H2NR1H3AAK1MAP2K4
SCHEMBL7111871 0.78 ERCC5 (0.47)
SCHEMBL7109630 0.78 CSF1R (0.38) AAK1
SCHEMBL5562146 0.77 AAK1 (0.39) AAK1
SCHEMBL7047983 0.76 AAK1 (0.33) AAK1PSEN1PSEN2APH1BNCSTN
SCHEMBL23927535 0.75 MAPT (0.34) PPARGPPARA
SCHEMBL7151045 0.74 CNR1 (0.41)
SCHEMBL27597100 0.74 MEN1 (0.47) MDM2PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed